Advertisements

Vega 100

Quick links to important sections

Vega 100

Advertisements
Advertisements

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Vega 100

Property Description
Active ingredient Sildenafil (as Sildenafil citrate)
Form Film-coated tablet (Oral dosage form)
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
General Function Facilitates enhanced blood flow dynamics
Origin Synthetic compound

Vega 100: Definition and Pharmacological Classification

Vega 100 is a synthetic medicinal product defined by its core active ingredient, Sildenafil, and its classification as a Phosphodiesterase type 5 (PDE5) inhibitor. This categorization places Sildenafil within a class of compounds utilized to modulate specific enzymes in the body. The regulatory status of Sildenafil as a prescription medicine is widely recognized across global pharmaceutical governing bodies. This compound is chemically derived, distinguishing it from natural or herbal products.

Composition, Form, and General Therapeutic Function

The fundamental composition of Vega 100 relies on the single active ingredient, Sildenafil, typically prepared as the citrate salt, combined with an inert base of solid excipients. The drug is consistently presented as an oral dosage form, specifically a compressed, film-coated tablet, which is designed for systemic delivery following ingestion by adult males. Sildenafil's primary function is to induce vasodilation by relaxing the smooth muscle surrounding blood vessels. This established effect supports the drug's general therapeutic goal of addressing circulatory limitations in relevant tissues.


Sildenafil: The Core of Vega 100’s Action

The physiological basis for Vega 100's action originates from Sildenafil's capacity for selective inhibition of the PDE5 enzyme. This targeted action prevents the accelerated degradation of the internal messenger molecule cGMP (cyclic Guanosine Monophosphate). The resulting accumulation of cGMP is the direct signal that triggers smooth muscle relaxation, which is the fundamental mechanism used to support increased and sustained blood flow necessary for the medication's intended physiological response.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

What side effects are possible with Vega 100?

Possible side effects and safety information

The official safety information for Vega 100 (Sildenafil) is structured by classifying possible adverse reactions according to how often they are expected to occur. These classifications range from very common, which are frequently reported, to rare, which are clinically significant but occur infrequently.

Very Common Adverse Reactions (1/10): The most frequently reported effects, often related to the medicine's vasodilatory action, include Headache and Flushing (facial redness/warmth).

Common Adverse Reactions (1/100 to < 1/10): These documented effects include Dizziness, Dyspepsia (indigestion), Nasal Congestion, and visual disturbances such as Blurred Vision or altered color perception (e.g., cyanopsia). Effects on the musculoskeletal system, such as Back Pain and Myalgia, are also classified in this range.

Serious Adverse Reactions (SARs)

The regulatory label documents rare but serious post-marketing events, primarily concerning the cardiovascular and ocular systems. These include Myocardial Infarction, Sudden Cardiac Death, Stroke, and a form of sudden vision loss known as Non-arteritic anterior ischemic optic neuropathy (NAION). Priapism (a prolonged erection lasting more than four hours) is also documented as a serious adverse reaction requiring prompt attention due to the risk of permanent penile tissue damage.

Population-Specific Safety Constraints

The medicine is subject to specific safety limitations as defined by government health authorities. It is formally contraindicated in patients who have a known hypersensitivity to Sildenafil or any component of the tablet. Use is also restricted for individuals with severe Hepatic Impairment, severe Hypotension (resting blood pressure < 90/50 mmHg), a recent history of Stroke or Myocardial Infarction, or specific Hereditary Degenerative Retinal Disorders.

Safety-Related Restrictions

Absolute contraindications exist against the use of Vega 100 concurrently with any form of Nitrates or Nitric Oxide Donors, and with Guanylate Cyclase Stimulators (e.g., riociguat), due to the risk of severe, life-threatening drops in blood pressure. The maximum hypotensive effect of Sildenafil is typically observed within 1 to 2 hours following administration.

The official safety information structures the risk understanding by classifying documented effects according to their frequency and the body system affected, ensuring clarity between common, expected reactions and rare, serious events. This regulatory framework defines specific constraints related to underlying cardiovascular disease, hepatic status, and concomitant use with certain vasodilatory medications.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes overdose from the active substance in Vega 100 as resulting in an increased rate and severity of common adverse reactions. Higher-than-prescribed exposure may lead to clinical manifestations such as hypotension (decreased blood pressure) and syncope (fainting). The management approach for an overdose is strictly symptomatic and supportive treatment, as regulatory documents confirm that no specific antidote is known, and the active substance is not expected to be cleared effectively by dialysis.

When Urgent Medical Assistance is Required

Immediate medical attention is mandated by official labeling for specific severe outcomes. Regulatory guidance requires patients to seek immediate medical assistance if they experience a prolonged erection (priapism) lasting four hours or longer. The patient must also stop taking the product and contact a medical professional right away upon the sudden onset of vision loss in one or both eyes or a sudden decrease or loss of hearing. Furthermore, urgent medical care is required for the development of severe cardiovascular symptoms, such as chest pain.

Overdose risk considerations are noted for individuals with severe hepatic or renal impairment, as these conditions can lead to increased plasma levels of the active substance.

Advertisements

Therapeutic Uses of Vega 100

What Vega 100 Treats: Main Uses and Benefits

Vega 100 is commonly used to help with two distinct conditions presenting with specific symptom patterns. This medication is applied across domains where additional symptomatic support is needed. The conditions for which it is commonly used include Functional Erectile Impairment in men and Pulmonary Arterial Hypertension (PAH) in adults.

Support and Symptom Relief

This treatment is relevant for easing symptoms related to physical discomfort and symptoms that interfere with daily functioning in adult males. It addresses symptom clusters associated with the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. For PAH, it is used for managing symptoms that interfere with daily functioning, such as reduced exercise capacity.

The medication may assist with maintaining functional stability and contributes to easing the overall symptom load when symptoms interfere with daily comfort.

“This application provides support that contributes to improved comfort and assists with maintaining functional stability in symptomatic periods.”

Quick Fact: Relief for Functional Limitations
This medication is used in situations involving certain distressing symptoms, which contributes to improved comfort during periods of heightened symptoms in both sexual and cardiopulmonary health contexts.

Regulatory References

  1. National Institutes of Health (NIH) StatPearls
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Vega 100?

Vega 100 (sildenafil) is subject to strict population eligibility rules defined by regulatory authorities. The medicine is officially indicated for adult men aged 18 years and older for the erectile dysfunction indication. Use is not indicated for women or children.

The medicine is contraindicated and must not be used by individuals taking organic nitrates or nitric oxide donors in any form, or those taking riociguat. Absolute prohibition also applies to patients with severe cardiovascular disorders (e.g., severe cardiac failure, recent myocardial infarction, or stroke) and those with severe hepatic impairment (Child-Pugh Class C).

Use of Vega 100 is conditional or requires caution in other populations. A lower starting dose is advised for patients with severe renal impairment and those with mild to moderate hepatic impairment. Caution is necessary for patients with certain blood disorders that may predispose them to priapism (e.g., sickle cell anemia) or with anatomical deformation of the penis. Older adults ( ge 65 years) may also require consideration for a lower initial dose.

Advertisements

What should I know about interactions with other medicines?

Vega 100 (sildenafil) can interact with several types of medicines, potentially leading to serious health consequences. Nitrate medicines in any form, including nitroglycerin, isosorbide dinitrate, and isosorbide mononitrate, are strictly contraindicated because co-administration can cause a sudden, severe, and dangerous drop in blood pressure. This severe interaction extends to other nitric oxide donors and guanylate cyclase stimulators, such as riociguat.

Caution is required when taking Vega 100 with alpha-blockers (often prescribed for high blood pressure or prostate issues), as this combination can also result in symptomatic low blood pressure (hypotension). Sildenafil is metabolised primarily by the CYP3A4 liver enzyme; therefore, medicines that inhibit this enzyme, such as certain HIV protease inhibitors (e.g., ritonavir, saquinavir) and some antifungal agents (e.g., ketoconazole, itraconazole), can significantly increase sildenafil concentration in the bloodstream. If these inhibitors are necessary, a dose reduction of sildenafil is typically required, with a maximum of 25 mg every 48 hours recommended when taken with ritonavir. It is also not recommended to combine Vega 100 with other treatments for erectile dysfunction or other PDE5 inhibitors.

Advertisements

Mechanism of Action

The action of Vega 100 is defined by the highly targeted modulation of an enzyme system responsible for regulating blood vessel dynamics, ensuring the drug’s physiological effects are local and cGMP-dependent.

Selective Enzyme Inhibition and cGMP Protection

The drug initiates its action through the competitive inhibition of Phosphodiesterase type 5 ( PDE5), the primary enzyme responsible for breaking down the vasodilatory messenger cyclic Guanosine Monophosphate (cGMP). This focused molecular blockade prevents the degradation of cGMP, thereby elevating its effective concentration and sustaining its presence within the arterial smooth muscle cells.

Augmentation of the Vascular Signaling Cascade

The elevated level of cGMP acts as a protected signal, sustaining the secondary messenger cascade. This signal activates Protein Kinase G (PKG), which orchestrates downstream cellular events that ultimately reduce intracellular calcium levels ( Ca^2+). This mechanism fundamentally serves to potentiate the natural Nitric Oxide ( NO) signal that initiates vasodilation, rather than generating the signal independently.

Modulation of Local Arterial Smooth Muscle Tone

The subsequent decrease in intracellular Ca^2+ causes the relaxation of the arterial walls, resulting in a localized reduction of vascular tone. This physiological change in the target tissue facilitates enhanced and sustained inflow of blood into the area, which constitutes the foundation of the drug's physiological action.

Advertisements

Dosage and Administration Information

How to Use Vega 100

Vega 100, which contains the active ingredient Sildenafil, is administered via the oral route as a film-coated tablet. Usage patterns follow two distinct regimens depending on the condition being addressed: an intermittent, as-needed regimen for functional erectile impairment (FEI) and a continuous, multiple-dose regimen for pulmonary arterial hypertension (PAH).


Administration and Dosing

Usage Regimen Standard Starting Dose Maximum Frequency / Interval
Intermittent Use (FEI) 50 mg (adjustable 25 mg to 100 mg) Not more than once daily (q24h)
Continuous Use (PAH) 20 mg (adjustable up to 80 mg) Three times a day (TID), doses 4 to 6 hours apart

For intermittent use, the oral tablet should be taken 30 minutes to 4 hours before anticipated activity. This dose is permitted to be taken with or without food, though absorption may be delayed by high-fat meals. For continuous use in PAH, doses must adhere to the 4 to 6 hour interval to maintain consistent therapy.


Population-Specific Use

Dose adjustments are specified for certain populations in the FEI context. A lower initial dose of 25 mg is typically considered for older adults (aged 65 and over) due to the potential for higher systemic exposure. This 25 mg starting dose is indicated for individuals with severe renal impairment or hepatic impairment. For the PAH regimen, no initial dose adjustment is required for these populations.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Vega 100


Evidence for use in Functional Erectile Impairment in Men

Research examining the use of Vega 100 for functional erectile impairment in men was based largely on a framework of short-term, placebo-controlled randomized controlled trials (RCTs). These studies monitored how symptoms evolved in the observed populations and were synthesized through multiple systematic reviews. Studies measured patient-reported outcomes describing perceived discomfort and scores from standardized questionnaires. Findings describe patterns observed in the studies where groups receiving the medication were associated with reported measurements related to erection status and the documented rate of successful attempts at sexual intercourse. However, follow-up durations were limited, meaning there is limited information for long-term outcomes beyond approximately six months of use.


Evidence for use in Pulmonary Arterial Hypertension (PAH)

Vega 100 was studied for the management of Pulmonary Arterial Hypertension (PAH), a condition marked by functional limitations and physiological strain. The evidence base includes pivotal, placebo-controlled RCTs that monitored outcomes reflecting daily functioning. Researchers examined the time to clinical worsening events and changes in functional capacity, primarily the 6-Minute Walk Distance (6MWD). Initial research in adults reported that studies examined measurements related to functional capacity in groups receiving the medication compared to placebo groups.


Long-term studies and follow-up duration

The evidence structure distinguishes between the initial short-term trials and long-term extension studies. For both uses, measurements of study outcomes were primarily derived from short-term research. The available data characterize short-term changes, but the certainty remains low regarding sustained, long-term effects. The research designs in these long-term phases were typically open-label. Long-term effects are not fully established, and continued research is ongoing to better characterize outcomes over multiple years.


What is still uncertain about Vega 100

One key limitation is the limited information for long-term outcomes from controlled trials. Furthermore, comparative evidence is lacking for Sildenafil against other oral treatments for erectile impairment. One key uncertainty relates to the evidence for the pediatric PAH population. The specific finding of a correlation between higher doses and observed mortality is documented in the research record for this group, remaining a significant area of discussion in the broader evidence landscape. Research provides context but not individual predictions, and findings describe group patterns, not personal outcomes.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vega 100 (FAQ)


Q: How quickly does Vega 100 start working after taking it?

Official prescribing information indicates that the concentration of the active ingredient in the bloodstream typically reaches its maximum level, known as Cmax, in about one hour after it is taken orally when fasting. This time frame describes when the drug is most concentrated in the body to produce its intended effects.


Q: How long do the effects of Vega 100 typically last?

Regulatory documents describe the elimination profile of the active ingredient. It has a terminal half-life of approximately 3 to 5 hours. This half-life is the time it takes for half of the drug to be cleared from the system, giving an indication of the overall duration of the drug’s systemic presence.


Q: Is Vega 100 known to cause dependency or addiction?

The active ingredient in Vega 100 is a PDE5 inhibitor, a type of medicine used for vascular conditions. According to general drug classifications and official product information, the substance is not described as having potential for physical dependence or being classified as a controlled substance.


Q: What happens if I miss a dose of Vega 100?

For the continuous-use regimen (for pulmonary arterial hypertension), official patient guidelines state that the next dose be taken as soon as possible. Official guidelines prohibit taking two doses at the same time to compensate for the one that was missed.


Q: Are there any common foods or drinks that should be avoided when using Vega 100?

Yes, regulatory documents contain an explicit warning against the use of grapefruit or grapefruit juice. This is because grapefruit can interact with the body’s enzymes responsible for breaking down the medicine, potentially leading to a higher concentration of the drug in the bloodstream.


Q: Can Vega 100 be used by people who have diabetes?

Clinical studies supporting the use of the drug for functional erectile impairment often included participants with coexisting health conditions, such as diabetes mellitus. Official documents for the drug do not list diabetes as a condition that prevents its use.


Q: Can I use Vega 100 if I am already taking medicine for high blood pressure?

Caution is advised in official product information if taking certain medicines for high blood pressure, specifically alpha-blockers or other antihypertensive agents. This combination may increase the risk of experiencing a symptomatic drop in blood pressure, known as hypotension.


Q: Is Vega 100 safe for elderly people (over 65)?

Official documents recognize that older adults (age 65 or older) may experience a higher concentration of the medicine in their system compared to younger adults. Because of this, regulatory guidance recommends that a lower starting dose be considered for this population.


Q: Does Vega 100 cure the underlying condition it treats, or only manage the symptoms?

The drug is characterized in official literature as working to manage symptoms associated with its indications, such as improving functional capacity or sustaining function. It is not characterized as a curative treatment for the underlying conditions it addresses.


Q: Is Vega 100 known to affect fertility in men or women?

Non-clinical data provided in regulatory documents, which are based on animal studies (rats and mice), indicated no observed effects on fertility. Specific, long-term human data on fertility related to the use of the medicine are generally complex and may not be fully established.


Q: Does Vega 100 affect my ability to drive or operate machinery?

The official product information notes that the medicine may cause adverse effects like dizziness or visual disturbances. Official product information suggests that individuals consider their reaction to the medication before engaging in activities like driving or operating machinery.


Q: What is the function of the '100' in the name Vega 100?

Official dosage and strength documents indicate that 100 mg is the highest single dose strength available for the intermittent-use regimen. It is likely that the number in the product name references this maximum dosage unit of the product.


Q: Do lifestyle factors, like smoking or drinking alcohol, impact the effectiveness of Vega 100?

Regulatory guidance describes that excessive alcohol consumption may be associated with an increased risk of experiencing headache, dizziness, or drops in blood pressure associated with the medicine.


Q: Is it important to take Vega 100 at the exact same time every day?

The importance of timing depends on the regimen. For intermittent use, it is taken as needed, not daily. For continuous use (for pulmonary arterial hypertension), official documents describe that doses are to be taken approximately 4 to 6 hours apart, which reflects a consistent daily timing requirement.


Q: Why is it advised to avoid grapefruit products when using Vega 100?

Official information advises this because grapefruit contains substances that can inhibit the CYP3A4 enzyme. This enzyme is crucial for breaking down the active ingredient in Vega 100. Inhibiting it can lead to higher-than-expected drug levels, increasing the risk of adverse reactions.


Q: Does Vega 100 require any special monitoring or follow-up tests?

Official documents outline the need for regular monitoring of pulmonary function and functional capacity for patients receiving the continuous-use regimen for pulmonary arterial hypertension ( PAH).


Q: Is Vega 100 linked to any changes in vision or hearing?

Official warnings document rare post-marketing reports of sudden decrease or loss of vision, known as NAION. Furthermore, rare cases of sudden decrease or loss of hearing have also been documented, sometimes accompanied by symptoms like dizziness or tinnitus (ringing in the ears).


Q: What are the common misunderstandings people have about how Vega 100 works?

A common point of clarification in official patient counseling information is that the drug does not generate the physiological response independently. It works by facilitating the body's natural response to stimulation, meaning that a form of stimulation is required for the intended effect to occur.


Q: Can Vega 100 be split or crushed to make it easier to swallow?

Vega 100 is supplied as a film-coated tablet designed to be swallowed whole. Official instructions and dosage form descriptions do not typically provide information or support for splitting, crushing, or otherwise altering the tablet prior to ingestion.


Q: Where can I find the official patient information leaflet for Vega 100?

Regulatory bodies require a Patient Information Leaflet (PIL) or Medication Guide to be distributed with the medicine to provide key facts. These documents are also often available publicly on official government drug databases, such as those maintained by the FDA or EMA.


Q: Are there any known long-term side effects that official documents mention?

Official research summaries and regulatory documents indicate that controlled clinical trial data on the long-term effects of the medicine is limited, meaning certainty regarding sustained long-term outcomes remains low. While research continues to characterize long-term outcomes, the available data primarily defines short-term changes.


Q: Why is the information online often inconsistent regarding Vega 100's use?

Official research summaries cite specific areas of complexity that lead to varying interpretations. These include factors like limited long-term controlled data, a lack of comparative evidence against other treatments, and complex findings regarding use in specific patient groups, which all contribute to external inconsistencies.

Advertisements

How should Vega 100 be stored and disposed of?

How to Store and Dispose of Vega 100

The storage and disposal of Vega 100 (Sildenafil) must adhere to official regulatory requirements to ensure product integrity and public safety.

Official Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). Do not store above 30 C.
Protection Keep the tablets in the original container and ensure the container is tightly closed to protect the medicine from moisture and light.
Child Safety The medication must be kept out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired Vega 100 must be disposed of in accordance with local regulatory requirements for pharmaceutical waste. Disposal into wastewater (flushing) is generally prohibited. It is recommended to use drug take-back programs when available, or to prepare the medicine for household trash disposal by mixing it with an undesirable substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vega 100 found in:

A-Z Index: